Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Contrast-enhanced EBUS in Lung Lesions and Intrathoracic Lymph Nodes

NCT07060378 is registered in ClinicalTrials.gov with Shanghai Chest Hospital as lead sponsor.

NCT NCT07060378
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07060378 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Contrast-enhanced EBUS in Lung Lesions and Intrathoracic Lymph Nodes
Lead sponsor
Shanghai Chest Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
July 10, 2025
Completion date
January 30, 2026
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung lesions, mediastinal and hilar lymph node enlargement